Iron reduction and cardiovascular outcomes [1]

JAMA

Volumn 297, Issue 19, 2007, Pages 2075-

  Sullivan, Jerome L ^a   Katz, Stuart D ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; IRON DEPLETION; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL; SYMPTOMATOLOGY; HEART INFARCTION; MORTALITY; OUTCOME ASSESSMENT; SCREENING; STROKE; BLOOD; CARDIOVASCULAR DISEASE; METABOLISM; NOTE; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHLEBOTOMY;

CARDIOVASCULAR DISEASES; FERRITINS; HUMANS; IRON; PERIPHERAL VASCULAR DISEASES; PHLEBOTOMY;

EID: 34248507184     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.19.2075-a     Document Type: Letter

References (5)

1. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
2. Zacharski LR, Chow BK, Howes PS, et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA. 2007;297:603-610.
3. Zheng H, Cable R, Spencer B, Votto N, Katz SD. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol. 2005;25:1577-1583.
4. Sullivan JL. Is stored iron safe? J Lab Clin Med. 2004;144:280-284.
5. Zacharski LR, Chow B, Lavori PW, et al. The Iron (Fe) and Atherosclerosis Study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J. 2000;139:337-345.